Trial intelligence / Profile preview

TRO19622 vs placebo in painful peripheral diabetic neuropathy

2006-004545-42Phase 2Completed

Sponsor
Trophos
Start
Jan 2007
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, double-blind trial in diabetic polyneuropathy (DPN) and diabetic neuropathy comparing TRO19622 500 mg QD with Placebo (2 arms). Primary endpoint: Mean 24-hour neuropathic pain score in final treatment week. Started Jan 2007; status: completed.

02

Drugs

olesoxime
03

Conditions

diabetic polyneuropathy (DPN)diabetic neuropathy

Beyond the preview

Go deeper on 2006-004545-42.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2006-004545-42.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call